Nulojix Lyophilisate For Solution For Injection 250Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

NULOJIX: Lyophilisate for solution for injection (250mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

BELATACEPT (Bel AT a sept) is used to help prevent rejection of a kidney transplant.

In-Depth Information

NULOJIX 250mg Powder for Injection

NDC: 000030371
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Kidney Transplant Rejection Prophylaxis

Storage Information
Opened product is stable in refrigerator (36 to 46 degrees F) for 24 hours
Store unreconstituted product in refrigerator (36 to 46 degrees F)
Store in original package until time of use
Protect from light
NULOJIX 250mg Powder for Injection

Reported Side Effects for NULOJIX 250mg Powder for Injection

Hair Loss Incidence:
<10.0%*
Severity: MILD
Onset: DELAYED
Kidney Failure Incidence:
<10.0%*
Severity: SEVERE
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Irregular Heart Beat Incidence:
<10.0%*
Severity: SEVERE
Onset: EARLY
Cyst Of Lymph Fluid Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Wound Dehiscence Incidence:
<10.0%*
Severity: SEVERE
Onset: DELAYED
Uncontrolled Urination Incidence:
<10.0%*
Severity: MODERATE
Onset: EARLY
Mouth Ulcers Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Excessive Sweating Incidence:
<10.0%*
Severity: MILD
Onset: DELAYED
Guillain-Barre Syndrome Incidence:
<10.0%*
Severity: SEVERE
Onset: DELAYED
Post-transplant Lymphoproliferative Disorder (PTLD) Incidence:
0.6-1.0%*
Severity: SEVERE
Onset: DELAYED
Antibody Formation Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Secondary Malignancy Incidence:
3.5%*
Severity: SEVERE
Onset: DELAYED
Diabetes Incidence:
5.0-8.0%*
Severity: MODERATE
Onset: DELAYED
High Uric Acid Level Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
Low Magnesium Levels Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
Shaking Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Acne Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Kidney Damage Incidence:
9.0%*
Severity: SEVERE
Onset: DELAYED
Stomach Pain Incidence:
9.0-19.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
10.0%*
Severity: MILD
Onset: DELAYED
Painful Urination Incidence:
11.0%*
Severity: MODERATE
Onset: EARLY
High Cholesterol Incidence:
11.0%*
Severity: MODERATE
Onset: DELAYED
Flu Incidence:
11.0%*
Severity: MILD
Onset: DELAYED
Shortness Of Breath Incidence:
12.0%*
Severity: MODERATE
Onset: EARLY
Low Calcium Levels Incidence:
13.0%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
13.0%*
Severity: MILD
Onset: DELAYED
Sore Throat Incidence:
13.0%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
15.0%*
Severity: MILD
Onset: EARLY
Increased Blood Sugar Incidence:
16.0%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
16.0%*
Severity: MODERATE
Onset: DELAYED
Protein In The Urine Incidence:
16.0%*
Severity: SEVERE
Onset: DELAYED
Joint Pain Incidence:
17.0%*
Severity: MILD
Onset: DELAYED
Low Blood Pressure Incidence:
18.0%*
Severity: MODERATE
Onset: RAPID
Low Phosphate Level Incidence:
19.0%*
Severity: MODERATE
Onset: DELAYED
High Potassium Level Incidence:
20.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
20.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
21.0%*
Severity: MILD
Onset: EARLY
Low Potassium Levels Incidence:
21.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
22.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
24.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
24.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
28.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
32.0%*
Severity: MODERATE
Onset: EARLY
Constipation Incidence:
33.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
34.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
39.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
45.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
82.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with NULOJIX

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5